Vita Coco’s Costco Contract Risk Now a Legal Catalyst—Market’s Growth Bet Under Fire

The market had been pricing in a clear story: Vita Coco's growth was accelerating. The stock's 12.8% climb over the last 120 days and a 63.5% surge over the past year reflected a powerful rally built on operational momentum. This wasn't just a speculative pop; it was a bet on execution. The company had backed it up with historically strong volume and earnings growth, added an experienced retail board member to its ranks, and maintained a "Moderate Buy" analyst consensus with an average price target above current levels. The narrative was one of a brand scaling successfully in a growing category.

Then came the legal probes. In recent days, firms like Pomerantz and Schall Law have initiated investigations into allegations that Vita Coco and its executives misled investors about critical operational issues. The focus is sharp: a report claiming the company was at risk of losing a major Costco contract accounting for 25% of its sales and facing operational issues including supply chain mismanagement. This is the core expectation gap. The market had priced in growth, but the new legal overhang directly challenges the foundation of that growth story.

The setup is classic "expectations vs. reality." The stock's strong uptrend shows robust growth was already priced in. The legal probes now introduce a wave of uncertainty that wasn't in the model. This creates a volatile dynamic where any news on the investigations can swing sentiment sharply, regardless of the company's underlying sales figures. The market is being forced to reassess whether the growth narrative is sustainable or if it was built on undisclosed risks.

The Core Risk: The $90 Million Revenue Gap and Contract Uncertainty

The central allegation is a direct hit to the revenue engine. The NINGI Research report claims Vita Coco was at risk of losing a major Costco contract that accounted for 25% of its sales. That's not a minor blip; it's a potential $90 million annual revenue shortfall. For a company whose stock had been rallying on growth, this is a fundamental expectation reset. The market had priced in continued expansion, but this risk suggests a core pillar of that growth was already crumbling.

What's most telling is the timeline. The report detailing this $90 million gap was published in March 2025. At the time, the stock did not collapse. This creates a classic "priced-in" scenario. The market had seen the warning and, for whatever reason, chose to look past it. The subsequent 12.8% climb over the last 120 days suggests investors were betting that Vita Coco would either retain the contract or that the growth story elsewhere would outweigh the risk. The legal probes now force a re-evaluation of that bet.

The stock's reaction in late March confirms the market is finally pricing in this specific revenue risk. Shares plunged to a new 52-week low, falling roughly 9% on the fraud investigation news. That move wasn't just about legal overhang; it was a direct repricing of the Costco contract threat. The fact that the investigation was launched on March 26, 2026, and the stock fell sharply within days, shows the market is treating the NINGI allegations as credible new evidence, not old news. The expectation gap has closed, and the reality of a $90 million hole is now in the model.

The bottom line is that Vita Coco's growth narrative was built on assumptions of operational stability and customer loyalty. The Costco contract risk, highlighted a year ago and now backed by formal investigations, directly challenges those assumptions. The stock's plunge signals that the market is no longer willing to ignore that risk. For the growth story to survive, Vita Coco must now prove it can replace or mitigate that lost revenue, a task that was not priced in just a few months ago.

Valuation and Catalysts: What's Left to Price In?

The stock's recent path shows a market caught between two forces. On one hand, the 8.98% drop over the last 20 days and 6.66% drop over the last 5 days signal heightened volatility and negative momentum, a direct reaction to the legal probes. On the other, the current price of $48.24 remains far from its 52-week high of $61.39, suggesting the worst-case revenue scenario isn't yet fully priced in. This gap is the arena for the next move.

The key catalysts are now binary. The company must deliver a credible response to the investigation and, more importantly, provide clear guidance on the Costco contract risk. A strong Q1 report could act as a reset button, offering evidence that the $90 million gap is overstated or manageable, thereby re-establishing some growth credibility. Conversely, any confirmation or new details that validate the NINGI report's claims would deepen the crisis, likely pushing the stock toward its 52-week low of $26.42.

The analyst consensus offers a path, but it's a conditional one. The average price target of $56.38 implies a recovery of roughly 17% from current levels. That target assumes the company can effectively manage the fallout and stabilize its narrative. However, it also reflects a view that the core business has value to protect. The stock's premium valuation metrics-like a forward P/E of 32.9-are built on growth expectations that are now in serious doubt. For the average target to be reached, Vita Coco must not only survive the legal overhang but also demonstrate that its operational foundation is stronger than the allegations suggest. Until then, the stock will remain a high-stakes bet on which reality wins out.